ArticleFrontiers in endocrinology2022

Partial Response After Toripalimab Plus Anlotinib for Advanced Metaplastic Breast Carcinoma: A Case Report.

Yang Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.